BCL2L1 and breast carcinoma: The results demonstrated that the expression of ZEB1 was positively correlated with those of Bcl-xL and cyclin D1 (Fig. 1d–h), highlighting that increased expression of ZEB1 contributes to the cellular mechanisms that mediate breast cancer chemoresistance.